SH 06 - Gynecological Cancer - Science Highlights

Presentations

• 09:15am - 09:20am ET

  Application Value of Whole-Process Individualized Intestinal Management in Radiotherapy for Gynecological Tumors: A Prospective Randomized Controlled Study

  Speaker: Fei Bai, - radiotherapy department, xi,an
• 09:20am - 09:25am ET

  Hypofractionated IMRT and Weekly Cisplatin in Patients with Stage IIB and IIIB-C1 Cervix Cancer: A Phase I/II Study - The HYPOTHESIS Trial

  Speaker: Heloisa de Andrade Carvalho, MD, PhD - University of São Paulo, Sao Paulo
• 09:25am - 09:30am ET

  Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study

  Speaker: Kamran Ahmed, MD - H. Lee Moffitt Cancer Center, Tampa
• 09:30am - 09:35am ET

  The Prognostic Role of Circulating Tumor DNA In Vulvovaginal Cancers Undergoing Radiotherapy

  Speaker: Bin Gui, MD, MS - UNC Health, Chapel Hill
• 09:35am - 09:40am ET

  Circulating Tumor DNA (ctDNA) as an Early Predictive Biomarker of Response In Locally Advanced Cervical Cancer Treated with the Interlace Regimen: A Preliminary Report

  Speaker: Bin Gui, MD, MS - UNC Health, Chapel Hill
• 09:40am - 09:45am ET

  Discussant

  Speaker: Lara Hathout, MD, FRCPC - Rutgers Cancer Institute , New Brunswick